Myco Pharmaceuticals Inc. of Cambridge, Mass., named BarryBerkowitz president and chief executive officer, WilliamTimberlake vice president for research, and Sean O'Connordirector of drug discovery. Berkowitz was founder, CEO,president and chairman of Magainin Sciences Inc. Timberlakewas research professor of genetics at the University of Georgia.And O'Connor was director of screening and biochemicalresearch at Bristol-Myers Squibb.

CytRx Corp. of Norcross, Ga., appointed John Flax vice president,medical and regulatory affairs. Flax was director of thecardiovascular section in Pfizer Inc.'s central research division.

The Liposome Company Inc. of Princeton, N.J., named DavidGordon vice president, U.S. clinical research, and GuenterKsionski vice president, international clinical research. Gordonwas director of biotechnology clinical research at the R.W.Johnson Pharmaceutical Research Institute. Ksionski was vicepresident for medical and regulatory affairs at LiposomeTechnology Inc. Additionally, Judith Lazar was named directorof international medical affairs.

Glycomed Inc. of Alameda, Calif., promoted to vice presidentsJohn Musser, chief scientist, medicinal chemistry; GregoryGiotta, chief intellectual property counsel; and James Swiedler,section head, cell genetics.

Gliatech Inc. of Cleveland named Louis Walcer vice president ofbusiness development and marketing. Walcer was director,business development and commercial analysis at Wyeth-Ayerst Laboratories, a division of American Home ProductsCorp.

Syntro Corp. of Kansas City, Mo., named Susan Strobel vicepresident of finance and administration, treasurer and chieffinancial officer. She was vice president of corporate finance atGeorge K. Baum & Co., a Midwestern banking firm.

Neurocrine Biosciences Inc. of San Diego named Nicholas Lingdirector of peptide chemistry and protein purification. Ling is asenior member and head of the department of molecularendocrinology at the Whittier Institute for Diabetes andEndocrinology.

(c) 1997 American Health Consultants. All rights reserved.

No Comments